Ayala Pharmaceuticals Inc (ADXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 01-2011 | 10-2010 | 07-2010 | 04-2010 | 01-2010 | |
| Sales | 0 | 0 | 177 | 87 | 0 |
| Gross Profit | N/A | N/A | 177 | 87 | N/A |
| Operating Expenses | 2,970 | 0 | 1,977 | 1,864 | 1,586 |
| Operating Income | -2,970 | N/A | -1,800 | -1,777 | -1,586 |
| Interest Expense | 532 | 0 | 316 | 1,647 | 1,666 |
| Other Income | 3,879 | 0 | 4,172 | -5,706 | -1,088 |
| Pre-tax Income | 377 | 0 | 2,055 | -9,130 | -4,340 |
| Income Tax | -380 | N/A | N/A | N/A | -279 |
| Net Income Continuous | 757 | N/A | 2,055 | -9,130 | -4,061 |
| Net Income | $757 | $N/A | $2,055 | $-9,130 | $-4,061 |
| EPS Basic Total Ops | 0.00 | N/A | 0.01 | -0.07 | -0.03 |
| EPS Basic Continuous Ops | 0.00 | N/A | 0.01 | -0.07 | -0.03 |
| EPS Diluted Total Ops | 0.00 | N/A | 0.01 | -0.07 | -0.03 |
| EPS Diluted Continuous Ops | 0.00 | N/A | 0.01 | -0.07 | -0.03 |
| EBITDA(a) | $-2,854 | $N/A | $-1,798 | $-1,449 | $-1,289 |